![Darrell Irvine](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Darrell Irvine
Fondateur chez
Elicio Therapeutics, Inc. (United States)
Profil
Darrell J.
Irvine is the founder of Ankyra Therapeutics, Inc., founded in 2019.
Dr. Irvine is the founder of Strand Therapeutics, Inc., founded in 2017.
Dr. Irvine is the founder of Elicio Therapeutics, Inc., founded in 2011.
Dr. Irvine is also the founder of Torque Therapeutics, Inc.,Elicio Therapeutics, Inc. (United States)..
Dr. Irvine is a Venture Partner at Catalio Capital Management LP.
Dr. Irvine earned a doctorate from Massachusetts Institute of Technology in 2000.
Dr. Irvine earned an undergraduate degree from the University of Pittsburgh in 1995.
Postes actifs de Darrell Irvine
| Sociétés | Poste | Début |
|---|---|---|
Elicio Therapeutics, Inc. (United States)
 Elicio Therapeutics, Inc. (United States) BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops novel immunotherapies for treatment of cancer and other diseases | Fondateur | - |
Catalio Capital Management LP
 Catalio Capital Management LP Investment ManagersFinance Catalio Capital invests in public and private companies located in the United States. The firm targets companies operating in the fields of life sciences developing next-generation drugs, devices and diagnostics, data, tools and innovative healthcare sectors. It provides financing for seed, early and later stage capital requirements and also makes co-investments. | Private Equity Investor | - |
Anciens postes connus de Darrell Irvine
| Sociétés | Poste | Fin |
|---|---|---|
| ELICIO THERAPEUTICS, INC. | Fondateur | - |
Strand Therapeutics, Inc.
 Strand Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company with a pipeline of mRNA therapeutics for cancers and autoimmune diseases | Fondateur | - |
Ankyra Therapeutics, Inc.
 Ankyra Therapeutics, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Fondateur | - |
Torque Therapeutics, Inc.
 Torque Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies to address cancers | Fondateur | - |
Formation de Darrell Irvine
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
96
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Elicio Therapeutics, Inc. (United States)
Elicio Therapeutics, Inc. (United States) BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops novel immunotherapies for treatment of cancer and other diseases | Health Technology |
University of Pittsburgh
 University of Pittsburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Torque Therapeutics, Inc.
Torque Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies to address cancers | Health Technology |
Strand Therapeutics, Inc.
Strand Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company with a pipeline of mRNA therapeutics for cancers and autoimmune diseases | Health Technology |
Ankyra Therapeutics, Inc.
Ankyra Therapeutics, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Catalio Capital Management LP
Catalio Capital Management LP Investment ManagersFinance Catalio Capital invests in public and private companies located in the United States. The firm targets companies operating in the fields of life sciences developing next-generation drugs, devices and diagnostics, data, tools and innovative healthcare sectors. It provides financing for seed, early and later stage capital requirements and also makes co-investments. | Finance |
Elicio Therapeutics, Inc.
 Elicio Therapeutics, Inc. BiotechnologyHealth Technology Develops cancer immunotherapies | Health Technology |
